title: Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.
abstract: Neuroendocrine tumors (NET) are usually slow-growing neoplasms carrying an overall favorable prognosis. Surgery, from resection to transplantation, remains the only potential curative option for these patients, and should always be considered. Nevertheless, because of very few randomized controlled trials available, the optimal treatment for these patients remains controversial, especially regarding the place of surgery. We herein discuss the place of surgical resection in the treatment strategy in neuroendocrine tumors of the digestive tract.
authors.affiliation: Departments of Hepato-Pancreato-Biliary Surgery and Transplantation, Beaujon Hospital, Assistance Publique Hôpitaux de Paris, Clichy, University Denis Diderot-Paris 7, Paris, France.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Gaujoux
authors.forename: Alain
authors.initials: A
authors.lastname: Sauvanet
authors.forename: Jacques
authors.initials: J
authors.lastname: Belghiti
mesh_terms: D005770:Gastrointestinal Neoplasms / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery*; D008495:Medical Oncology / Q000379:methods*; D009362:Neoplasm Metastasis; D018358:Neuroendocrine Tumors / Q000473:pathology / Q000601:surgery*; D011379:Prognosis; D013514:Surgical Procedures, Operative / Q000379:methods*; D016896:Treatment Outcome